Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Borras-Blasco

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Healthcare Quality Research|November 10, 2023
[The value of persistence in the 5P Medicine model for chronic diseases]J Borras-Blasco, E Ramírez-Herráiz, A Navarro Ruiz
British Journal of Rheumatology|November 24, 1998
Alfuzosin-associated dermatomyositisP Vela-Casasempere, J Borras-Blasco, A Navarro-Ruiz
Journal of Clinical Pharmacy and Therapeutics|January 30, 2004
Evaluation of once daily tobramycin dosing in critically ill patients through Bayesian simulationJ F Peris-Marti, J Borras-Blasco, J D Rosique-Robles, et al.
Archivos De La Sociedad Espanola De Oftalmologia|December 4, 2004
[Treatment of persistent epithelial defects using autologous serum application]M C Alvarado Valero, J J Martínez Toldos, J Borras Blasco, et al.
Actas Dermo-Sifiliograficas|December 14, 2025
Long-term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-world Retrospective Multicenter Study From SpainJ F Silvestre-Salvador, S Santos-Alarcón, A Mengual-Sendra, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Healthcare Quality Research|November 10, 2023
[The value of persistence in the 5P Medicine model for chronic diseases]J Borras-Blasco, E Ramírez-Herráiz, A Navarro Ruiz
British Journal of Rheumatology|November 24, 1998
Alfuzosin-associated dermatomyositisP Vela-Casasempere, J Borras-Blasco, A Navarro-Ruiz
Journal of Clinical Pharmacy and Therapeutics|January 30, 2004
Evaluation of once daily tobramycin dosing in critically ill patients through Bayesian simulationJ F Peris-Marti, J Borras-Blasco, J D Rosique-Robles, et al.
Archivos De La Sociedad Espanola De Oftalmologia|December 4, 2004
[Treatment of persistent epithelial defects using autologous serum application]M C Alvarado Valero, J J Martínez Toldos, J Borras Blasco, et al.
Actas Dermo-Sifiliograficas|December 14, 2025
Long-term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-world Retrospective Multicenter Study From SpainJ F Silvestre-Salvador, S Santos-Alarcón, A Mengual-Sendra, et al.
Pageof 1